These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28865294)

  • 1. Thiazolo[4,5-d]pyridazine analogues as a new class of dihydrofolate reductase (DHFR) inhibitors: Synthesis, biological evaluation and molecular modeling study.
    Ewida MA; Abou El Ella DA; Lasheen DS; Ewida HA; El-Gazzar YI; El-Subbagh HI
    Bioorg Chem; 2017 Oct; 74():228-237. PubMed ID: 28865294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imidazo[2',1':2,3]thiazolo[4,5-d]pyridazinone as a new scaffold of DHFR inhibitors: Synthesis, biological evaluation and molecular modeling study.
    Ewida MA; Abou El Ella DA; Lasheen DS; Ewida HA; El-Gazzar YI; El-Subbagh HI
    Bioorg Chem; 2018 Oct; 80():11-23. PubMed ID: 29864684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, biological evaluation and molecular modeling study of new (1,2,4-triazole or 1,3,4-thiadiazole)-methylthio-derivatives of quinazolin-4(3H)-one as DHFR inhibitors.
    El-Gazzar YI; Georgey HH; El-Messery SM; Ewida HA; Hassan GS; Raafat MM; Ewida MA; El-Subbagh HI
    Bioorg Chem; 2017 Jun; 72():282-292. PubMed ID: 28499189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-Methyl-imidazo[2,1-b]thiazole derivatives as a new class of antifolates: Synthesis, in vitro/in vivo bio-evaluation and molecular modeling simulations.
    Ewida MA; Ewida HA; Ahmed MS; Allam HA; ElBagary RI; George RF; Georgey HH; El-Subbagh HI
    Bioorg Chem; 2021 Oct; 115():105205. PubMed ID: 34329992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, biological evaluation and molecular modeling study of 2-(1,3,4-thiadiazolyl-thio and 4-methyl-thiazolyl-thio)-quinazolin-4-ones as a new class of DHFR inhibitors.
    Al-Rashood ST; Hassan GS; El-Messery SM; Nagi MN; Habib EE; Al-Omary FAM; El-Subbagh HI
    Bioorg Med Chem Lett; 2014 Sep; 24(18):4557-4567. PubMed ID: 25139568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonclassical antifolates, part 4. 5-(2-aminothiazol-4-yl)-4-phenyl-4H-1,2,4-triazole-3-thiols as a new class of DHFR inhibitors: synthesis, biological evaluation and molecular modeling study.
    Hassan GS; El-Messery SM; Al-Omary FA; Al-Rashood ST; Shabayek MI; Abulfadl YS; Habib el-SE; El-Hallouty SM; Fayad W; Mohamed KM; El-Menshawi BS; El-Subbagh HI
    Eur J Med Chem; 2013 Aug; 66():135-45. PubMed ID: 23792351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting dihydrofolate reductase: Design, synthesis and biological evaluation of novel 6-substituted pyrrolo[2,3-d]pyrimidines as nonclassical antifolates and as potential antitumor agents.
    Gao T; Zhang C; Shi X; Guo R; Zhang K; Gu J; Li L; Li S; Zheng Q; Cui M; Cui M; Gao X; Liu Y; Wang L
    Eur J Med Chem; 2019 Sep; 178():329-340. PubMed ID: 31200235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydrofolate reductase inhibition effect of 5-substituted pyrido[2,3-d]pyrimidines: Synthesis, antitumor activity and molecular modeling study.
    Abdelaziz OA; El Husseiny WM; Selim KB; Eisa HM
    Bioorg Chem; 2019 Sep; 90():103076. PubMed ID: 31260878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity.
    Ng HL; Chen S; Chew EH; Chui WK
    Eur J Med Chem; 2016 Jun; 115():63-74. PubMed ID: 26994844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of novel 6-substituted pyrrolo [3,2-d] pyrimidine analogues as antifolate antitumor agents.
    Tian C; Wang M; Han Z; Fang F; Zhang Z; Wang X; Liu J
    Eur J Med Chem; 2017 Sep; 138():630-643. PubMed ID: 28711701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and in vitro antitumor evaluation of new thieno[2,3-d]pyrimidine derivatives as EGFR and DHFR inhibitors.
    Fouad MM; Ghabbour HA; Shehata IA; El-Ashmawy MB
    Bioorg Chem; 2024 Jul; 148():107401. PubMed ID: 38749115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, molecular modeling simulations and anticancer activity of some new Imidazo[2,1-b]thiazole analogues as EGFR/HER2 and DHFR inhibitors.
    Moharram EA; El-Sayed SM; Ghabbour HA; El-Subbagh HI
    Bioorg Chem; 2024 Sep; 150():107538. PubMed ID: 38861913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonclassical antifolates, part 3: synthesis, biological evaluation and molecular modeling study of some new 2-heteroarylthio-quinazolin-4-ones.
    Al-Omary FA; Hassan GS; El-Messery SM; Nagi MN; Habib el-SE; El-Subbagh HI
    Eur J Med Chem; 2013 May; 63():33-45. PubMed ID: 23454532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of dihydrofolate reductase as antitumor agents: design, synthesis and biological evaluation of a series of novel nonclassical 6-substituted pyrido[3,2-d]pyrimidines with a three- to five-carbon bridge.
    Li H; Fang F; Liu Y; Xue L; Wang M; Guo Y; Wang X; Tian C; Liu J; Zhang Z
    Bioorg Med Chem; 2018 May; 26(9):2674-2685. PubMed ID: 29691154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human dihydrofolate reductase inhibition effect of 1-Phenylpyrazolo[3,4-d]pyrimidines: Synthesis, antitumor evaluation and molecular modeling study.
    Salem IM; Mostafa SM; Salama I; El-Sabbagh OI; A H Hegazy W; Ibrahim TS
    Bioorg Chem; 2022 Dec; 129():106207. PubMed ID: 36270170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of N-{4-[(2,4-diamino-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid and N-{4-[(2-amino-4-oxo-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid as dual inhibitors of dihydrofolate reductase and thymidylate synthase and as potential antitumor agents.
    Gangjee A; Lin X; Kisliuk RL; McGuire JJ
    J Med Chem; 2005 Nov; 48(23):7215-22. PubMed ID: 16279780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational modification of the lead molecule: Enhancement in the anticancer and dihydrofolate reductase inhibitory activity.
    Kaur J; Kaur S; Singh P
    Bioorg Med Chem Lett; 2016 Apr; 26(8):1936-40. PubMed ID: 26979156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, dihydrofolate reductase inhibition, antitumor testing, and molecular modeling study of some new 4(3H)-quinazolinone analogs.
    Al-Rashood ST; Aboldahab IA; Nagi MN; Abouzeid LA; Abdel-Aziz AA; Abdel-Hamide SG; Youssef KM; Al-Obaid AM; El-Subbagh HI
    Bioorg Med Chem; 2006 Dec; 14(24):8608-21. PubMed ID: 16971132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antiproliferative activity of a series of novel 6-substituted pyrido[3,2-d]pyrimidines as potential nonclassical lipophilic antifolates targeting dihydrofolate reductase.
    Wang M; Yang J; Yuan M; Xue L; Li H; Tian C; Wang X; Liu J; Zhang Z
    Eur J Med Chem; 2017 Mar; 128():88-97. PubMed ID: 28152430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antiparasitic and antitumor activity of 2, 4-diamino-6-(arylmethyl)-5,6,7,8-tetrahydroquinazoline analogues of piritrexim.
    Rosowsky A; Papoulis AT; Forsch RA; Queener SF
    J Med Chem; 1999 Mar; 42(6):1007-17. PubMed ID: 10090784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.